Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / MDNA - Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q4 2022 Results - Earnings Call Transcript

MDNA - Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q4 2022 Results - Earnings Call Transcript

Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. (MDNA) Q4 2022 Earnings Conference Call June 22, 2022 8:30 AM ET Company Participants Dan Ferry - IR, LifeSci Advisors Fahar Merchant - President & CEO Martin Bexon - CMO Liz Williams - CFO Conference Call Participants Matt Biegler - Oppenheimer David Martin - Bloom Burton Catherine Novack - JonesTrading Swayampakula Ramakanth - H.C. Wainwright Andre Uddin - Mackie Research Capital Shubhendu Roy - Brookline Capital Markets David Bautz - Zacks Small-Cap Research Presentation Operator Hello, and welcome to the Medicenna Therapeutics Fiscal Year-End Earnings Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end of this call. [Operator Instructions] Please be advised that this call is being recorded at the company’s request. I would now like to turn the call over to Dan Ferry of LifeSci Advisors. Dan, please go ahead. Dan Ferry Thank you, operator, and thank

For further details see:

Medicenna Therapeutics Corp. (MDNA) CEO Fahar Merchant on Q4 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Medicenna Therapeutics Corp.
Stock Symbol: MDNA
Market: NASDAQ
Menu
MDNA MDNA Quote MDNA Short MDNA News MDNA Articles MDNA Message Board
Get MDNA Alerts

News, Short Squeeze, Breakout and More Instantly...